secwatch.observer — SEC 8-K summary
======================================

Issuer:     RxSight, Inc. (RXST)
CIK:        0001111485
Form:       8-K
Filed at:   2023-11-09T23:59:59+00:00
Accession:  0000950170-23-062039
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

RxSight Q3 revenue up 76% to $22.2M; raises FY2023 guidance
-----------------------------------------------------------

- Q3 revenue $22.2M (+76% YoY); net loss $(12.4)M, EPS $(0.35); adjusted net loss $(6.9)M, adj. EPS $(0.19)
- Sold 66 LDDs (installed base 589, +72% YoY); LAL procedure volumes 13,657 (+107% YoY)
- Raised FY2023 revenue guidance to $85-87M (prior $81-86M); gross margin guidance 60-61% (prior 58-60%)
- Eliminated remaining $20M term loan; expects to reduce annualized interest expense by ~$5.6M
- Raised $11.7M net via ATM facility; cash/short-term investments $131.9M at quarter end

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1111485/000095017023062039/0000950170-23-062039-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1111485/000095017023062039/rxst-20231109.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-062039

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer